Literature DB >> 19780929

Guidelines for the diagnosis and treatment of canine chronic valvular heart disease.

C Atkins1, J Bonagura, S Ettinger, P Fox, S Gordon, J Haggstrom, R Hamlin, B Keene, V Luis-Fuentes, R Stepien.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19780929     DOI: 10.1111/j.1939-1676.2009.0392.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


× No keyword cloud information.
  118 in total

1.  Evaluation of serum myeloperoxidase concentration in dogs with heart failure due to chronic mitral valvular insufficiency.

Authors:  Jong-In Park; Sang-Il Suh; Changbaig Hyun
Journal:  Can J Vet Res       Date:  2017-01       Impact factor: 1.310

Review 2.  Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.

Authors:  Mark A Oyama; Chad Elliott; Kerry A Loughran; Alexander P Kossar; Estibaliz Castillero; Robert J Levy; Giovanni Ferrari
Journal:  Cardiovasc Pathol       Date:  2020-01-07       Impact factor: 2.185

3.  Polymorphism, coupling interval and prematurity index in dogs with degenerative mitral valve disease and ventricular arrhythmias.

Authors:  Elizabeth Regina Carvalho; Roberto Andrés Navarrete Ampuero; Giovana Laís Ruviaro Tuleski; Aparecido Antonio Camacho; Marlos Gonçalves Sousa
Journal:  Vet Res Commun       Date:  2018-03-13       Impact factor: 2.459

Review 4.  Translating stem cell therapies: the role of companion animals in regenerative medicine.

Authors:  Susan W Volk; Christine Theoret
Journal:  Wound Repair Regen       Date:  2013-04-29       Impact factor: 3.617

5.  Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.

Authors:  Jonathan P Mochel; Martin Fink; Mathieu Peyrou; Antoine Soubret; Jérôme M Giraudel; Meindert Danhof
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

6.  Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.

Authors:  Eric de Madron; Jonathan N King; Günther Strehlau; Regina Valle White
Journal:  Can Vet J       Date:  2011-11       Impact factor: 1.008

7.  Evaluation of growth differentiation factor 11 (GDF11) levels in dogs with chronic mitral valve insufficiency.

Authors:  Sung-Taek Ahn; Sang-Il Suh; Hyeongsun Moon; Changbaig Hyun
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

8.  Antioxidative enzyme activity and total antioxidant capacity in serum of dogs with degenerative mitral valve disease.

Authors:  Marcin Michałek; Aleksandra Tabiś; Alicja Cepiel; Agnieszka Noszczyk-Nowak
Journal:  Can J Vet Res       Date:  2020-01       Impact factor: 1.310

9.  Evaluation of red blood cell distribution width in dogs with various illnesses.

Authors:  Carlos Martinez; Carmel T Mooney; Robert E Shiel; Pak Kan Tang; Louise Mooney; Emma J O'Neill
Journal:  Can Vet J       Date:  2019-09       Impact factor: 1.008

10.  Comparison of electrocardiographic parameters in dogs with different stages of myxomatous mitral valve disease.

Authors:  Yejin Na; Dohee Lee; Taesik Yun; Yoonhoi Koo; Yeon Chae; Hakhyun Kim; Mhan-Pyo Yang; Byeong-Teck Kang
Journal:  Can J Vet Res       Date:  2021-10       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.